What is Ingredion Incorporated's earnings per share (EPS)?

Ingredion Incorporated (INGR) reported diluted earnings per share of $11.18 for fiscal year 2025. This represents a 15.1% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Ingredion Incorporated (INGR) Financials

INGR

Trailing 12 months to June 30, 2026

Revenue $7.2B -1.4% YoY

Net Income $592.0M -12.4% YoY

EPS (Diluted) $9.17 -10.5% YoY

Free Cash Flow $355.0M -56.1% YoY

Market Cap $6.0B as of Oct 10, 2026

Price / Sales 0.8x on $7.2B revenue, trailing 12 months to June 30, 2026

Price / Earnings 10.1x on $592.0M net income, trailing 12 months to June 30, 2026

Price / Book 1.3x on $4.5B equity, Q2 FY2026

A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 10, 2026; every other figure is from the SEC filings on this page. Not financial advice.

Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Aug 7, 2026 Currency USD FYE December

Newest figures come from the 10-Q for Q2 FY2026, filed Aug 7, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the INGR SEC filings page.

Ingredion Incorporated (INGR) reported $7.2B in revenue over the twelve months to Jun 30, 2026, down 1.4% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI INGR FY2025 2026-10-03

Ingredion is converting a smaller revenue base into higher margins, while heavier investment reduced cash available after operations.

Revenue was lower in FY2025 than FY2023, yet gross margin climbed from 21.4% to 25.3%. That pattern points to margin expansion from mix or cost structure rather than volume growth; the figures do not isolate which mechanism.

Net income increased while operating cash flow decreased, so accounting profit converted less cleanly into cash in FY2025. Capital spending rose from $295M to $433M, which helps explain why free cash flow weakened even as margins improved.

Liabilities stayed roughly flat while equity increased from $3.804B to $4.274B, shifting financing toward equity rather than additional obligations. Debt-to-equity ended at 0.4x while current ratio was 2.7x, indicating a less leveraged and more liquid balance-sheet structure.

Financial Health Signals

Financial Health Score 60/100

Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of Ingredion Incorporated's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Profitability

Ingredion Incorporated has an operating margin of 14.1%, meaning the company retains $14 of operating profit per $100 of revenue. This strong profitability earns a score of 71/100, reflecting efficient cost management and pricing power. This is up from 11.9% the prior year.

Growth

Ingredion Incorporated's revenue declined 2.8% year-over-year, from $7.4B to $7.2B. This contraction results in a growth score of 14/100.

Leverage

Ingredion Incorporated has a moderate D/E ratio of 0.41. This balance of debt and equity financing earns a leverage score of 58/100.

Liquidity

With a current ratio of 2.66, Ingredion Incorporated holds $2.66 in current assets for every $1 of short-term obligations. This comfortable liquidity earns a score of 73/100.

Cash Flow

Ingredion Incorporated converts 7.1% of revenue into free cash flow ($511.0M). This strong cash generation earns a score of 65/100.

Returns

Ingredion Incorporated earns a strong 17.1% return on equity (ROE), meaning it generates $17 of profit for every $100 of shareholders' equity. This efficient capital use earns a returns score of 78/100. This is up from 17.0% the prior year.

Altman Z-Score Safe

3.68

Ingredion Incorporated scores 3.68, well above the 2.99 safe threshold. This indicates low bankruptcy risk based on profitability, leverage, and asset efficiency.

Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.

Piotroski F-Score Strong

8/9

Ingredion Incorporated passes 8 of 9 financial strength tests. All 4 profitability signals pass (positive income, cash flow, and earnings quality), all 3 leverage/liquidity signals pass, 1 of 2 efficiency signals pass.

Earnings Quality Cash-Backed

1.29x

For every $1 of reported earnings, Ingredion Incorporated generates $1.29 in operating cash flow ($944.0M OCF vs $729.0M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$1.9B

YoY+0.9%

QoQ+3.2%

5Y CAGR+1.0%

10Y CAGR+2.4%

Ingredion Incorporated generated $1.9B in revenue in Q2 2026. This represents an increase of 0.9% from the same quarter a year earlier. Against the prior quarter it is up 3.2%.

EBITDA

$243.0M

YoY-25.0%

QoQ-5.8%

Ingredion Incorporated's EBITDA was $243.0M in Q2 2026, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 25.0% from the same quarter a year earlier. Against the prior quarter it is down 5.8%.

Net Income

$114.0M

YoY-41.8%

QoQ-19.7%

5Y CAGR-8.5%

10Y CAGR-0.3%

Ingredion Incorporated reported $114.0M in net income in Q2 2026. This represents a decrease of 41.8% from the same quarter a year earlier. Against the prior quarter it is down 19.7%.

EPS (Diluted)

$1.78

YoY-40.5%

QoQ-19.8%

5Y CAGR-7.4%

10Y CAGR+1.2%

Ingredion Incorporated earned $1.78 per diluted share (EPS) in Q2 2026. This represents a decrease of 40.5% from the same quarter a year earlier. Against the prior quarter it is down 19.8%.

Cash & Balance Sheet

Free Cash Flow

-$10.0M

YoY-111.9%

QoQ+87.0%

Ingredion Incorporated recorded an outflow of $10.0M in free cash flow in Q2 2026, representing a cash shortfall after capex. This represents a decrease of 111.9% from the same quarter a year earlier. Against the prior quarter it is up 87.0%.

Cash & Debt

$948.0M

YoY+10.1%

QoQ+3.7%

5Y CAGR+11.8%

10Y CAGR+6.9%

Ingredion Incorporated held $948.0M in cash against $1.7B in long-term debt as of Q2 2026.

Dividends Per Share

$0.82

YoY+2.5%

QoQ0.0%

5Y CAGR+5.1%

10Y CAGR+6.2%

Ingredion Incorporated paid $0.82 per share in dividends in Q2 2026. This represents an increase of 2.5% from the same quarter a year earlier. It is unchanged from the prior quarter.

Shares Outstanding

63M

YoY-1.7%

QoQ0.0%

5Y CAGR-1.2%

10Y CAGR-1.3%

Ingredion Incorporated had 63M shares outstanding in Q2 2026. This represents a decrease of 1.7% from the same quarter a year earlier. It is unchanged from the prior quarter.

Margins & Returns

Gross Margin

23.0%

YoY-3.0pp

QoQ+0.7pp

5Y change+2.2pp

10Y change-1.4pp

Ingredion Incorporated's gross margin was 23.0% in Q2 2026, indicating the percentage of revenue retained after direct costs. This is down 3.0 percentage points from the same quarter a year earlier. Against the prior quarter it is up 0.7 percentage points.

Operating Margin

10.2%

YoY-4.6pp

QoQ-1.2pp

Ingredion Incorporated's operating margin was 10.2% in Q2 2026, reflecting core business profitability. This is down 4.6 percentage points from the same quarter a year earlier. Against the prior quarter it is down 1.2 percentage points.

Net Margin

6.2%

YoY-4.5pp

QoQ-1.8pp

5Y change-3.9pp

10Y change-1.9pp

Ingredion Incorporated's net profit margin was 6.2% in Q2 2026, showing the share of revenue converted to profit. This is down 4.5 percentage points from the same quarter a year earlier. Against the prior quarter it is down 1.8 percentage points.

Return on Equity

2.5%

YoY-2.1pp

QoQ-0.7pp

5Y change-3.8pp

10Y change-2.3pp

Ingredion Incorporated's ROE was 2.5% in Q2 2026, measuring profit generated per dollar of shareholder equity. This is down 2.1 percentage points from the same quarter a year earlier. Against the prior quarter it is down 0.7 percentage points.

Capital Allocation

Capital Expenditures

$100.0M

YoY-1.0%

QoQ-9.1%

5Y CAGR+14.0%

Ingredion Incorporated invested $100.0M in capex in Q2 2026, funding long-term assets and infrastructure. This represents a decrease of 1.0% from the same quarter a year earlier. Against the prior quarter it is down 9.1%.

R&D Spending

Not reported for Q2 2026.

Share Buybacks

Not reported for Q2 2026.

INGR Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

INGR quarterly income statement

Metric	TTM	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Revenue	$7.2B	$7.2B-2.8%	$7.4B-8.9%	$8.2B+2.7%	$7.9B+15.3%	$6.9B+15.1%	$6.0B-3.6%	$6.2B-1.3%	$6.3B+0.7%	$6.2B+9.5%	$5.7B+1.5%	$5.6B-0.8%	$5.7B-10.4%	$6.3B-3.1%	$6.5B+5.0%	$6.2B
Cost of Revenue	N/A	$5.4B-4.4%	$5.6B-12.0%	$6.4B-0.6%	$6.5B+16.0%	$5.6B+18.0%	$4.7B-3.7%	$4.9B-0.5%	$4.9B+3.1%	$4.8B+10.9%	$4.3B-1.7%	$4.4B-3.8%	$4.6B-12.4%	$5.2B-1.8%	$5.3B+3.9%	$5.1B
Gross Profit	$1.7B	$1.8B+2.1%	$1.8B+2.4%	$1.7B+17.1%	$1.5B+12.2%	$1.3B+4.6%	$1.3B-3.0%	$1.3B-4.1%	$1.4B-7.1%	$1.5B+5.1%	$1.4B+12.8%	$1.2B+11.4%	$1.1B-1.4%	$1.1B-8.6%	$1.2B+9.9%	$1.1B
R&D Expenses	N/A	$71.0M+6.0%	$67.0M+6.3%	$63.0M+21.2%	$52.0M+20.9%	$43.0M0.0%	$43.0M-2.3%	$44.0M	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
SG&A Expenses	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	$579.0M+4.3%	$555.0M+5.7%	$525.0M-1.7%	$534.0M-4.0%	$556.0M+2.4%	$543.0M
Operating Income	N/A	$1.0B+15.1%	$883.0M-7.7%	$957.0M+25.6%	$762.0M+145.8%	$310.0M-46.7%	$582.0M-12.3%	$664.0M-5.5%	$703.0M-15.9%	$836.0M+3.7%	$806.0M+22.1%	$660.0M+13.6%	$581.0M-5.2%	$613.0M-8.2%	$668.0M-0.4%	$671.0M
EBITDA	N/A	$1.2B+12.9%	$1.1B-6.7%	$1.2B+20.4%	$977.0M+84.3%	$530.0M-33.3%	$795.0M-10.1%	$884.0M-6.9%	$950.0M-9.1%	$1.0B+4.3%	$1.0B+17.3%	$854.0M+10.1%	$776.0M-3.8%	$807.0M-8.2%	$879.0M-0.3%	$882.0M
Income Tax	N/A	$238.0M-14.1%	$277.0M+47.3%	$188.0M+13.3%	$166.0M+35.0%	$123.0M-19.1%	$152.0M-3.8%	$158.0M-5.4%	$167.0M-29.5%	$237.0M-3.7%	$246.0M+31.6%	$187.0M+19.1%	$157.0M+9.0%	$144.0M-13.8%	$167.0M-1.8%	$170.0M
Net Income	$592.0M	$729.0M+12.7%	$647.0M+0.6%	$643.0M+30.7%	$492.0M+320.5%	$117.0M-66.4%	$348.0M-15.7%	$413.0M-6.8%	$443.0M-14.6%	$519.0M+7.0%	$485.0M+20.6%	$402.0M+13.2%	$355.0M-10.4%	$396.0M-7.5%	$428.0M+1.2%	$423.0M
EPS (Basic)	N/A	$11.36+15.0%	$9.88+1.4%	$9.74+31.1%	$7.43+327.0%	$1.74-66.4%	$5.18-16.0%	$6.17-1.3%	$6.25-13.3%	$7.21+7.6%	$6.70+19.2%	$5.62+16.6%	$4.82-6.2%	$5.14-8.1%	$5.59+2.8%	$5.44
EPS (Diluted)	$9.17	$11.18+15.1%	$9.71+1.1%	$9.60+30.8%	$7.34+324.3%	$1.73-66.4%	$5.15-16.0%	$6.13-0.6%	$6.17-12.6%	$7.06+7.8%	$6.55+18.9%	$5.51+16.2%	$4.74-6.1%	$5.05-7.7%	$5.47+2.8%	$5.32
Diluted Shares (Avg)	N/A	65M-2.1%	67M-0.6%	67M0.0%	67M-1.2%	68M+0.3%	68M+0.3%	67M-6.1%	72M-2.3%	74M-0.8%	74M+1.5%	73M-2.5%	75M-4.3%	78M+0.1%	78M0.0%	78M

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-K	Q3'2510-K	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-K
Revenue	$1.9B+0.9%	$1.8B-1.2%	$1.8B-2.4%	$1.8B-2.9%	$1.8B-2.4%	$1.8B-3.7%	$1.8B-6.3%	$1.9B-8.0%
Cost of Revenue	$1.4B+5.0%	$1.4B+3.3%	N/A	$1.4B-2.2%	$1.4B-5.3%	$1.3B-8.1%	N/A	$1.4B-13.7%
Gross Profit	$426.0M-10.7%	$401.0M-13.9%	$430.0M-4.2%	$455.0M-5.0%	$477.0M+7.0%	$466.0M+11.8%	$449.0M+12.3%	$479.0M+13.8%
Operating Income	$188.0M-30.6%	$203.0M-26.4%	N/A	$249.0M-7.1%	$271.0M+12.9%	$276.0M+29.6%	N/A	$268.0M+25.8%
EBITDA	$243.0M-25.0%	$258.0M-22.1%	N/A	$306.0M-4.7%	$324.0M+10.2%	$331.0M+24.4%	N/A	$321.0M+19.3%
Income Tax	$59.0M-3.3%	$50.0M-26.5%	N/A	$69.0M-17.9%	$61.0M-23.8%	$68.0M+17.2%	N/A	$84.0M+236.0%
Net Income	$114.0M-41.8%	$142.0M-27.9%	$165.0M+73.7%	$171.0M-9.0%	$196.0M+32.4%	$197.0M-8.8%	$95.0M-27.5%	$188.0M+19.0%
EPS (Basic)	$1.80-40.8%	$2.25-26.2%	$2.59+77.4%	$2.66-7.6%	$3.04+35.1%	$3.05-7.3%	$1.46-27.0%	$2.88+20.5%
EPS (Diluted)	$1.78-40.5%	$2.22-26.0%	$2.56+79.0%	$2.61-7.8%	$2.99+34.7%	$3.00-7.1%	$1.43-27.4%	$2.83+19.9%
Diluted Shares (Avg)	64M-2.6%	64M-2.4%	N/A	65M-1.7%	66M-1.8%	66M-1.8%	N/A	67M-0.7%

Not reported in any period shown, so not listed: R&D Expenses, SG&A Expenses, Interest Expense.

INGR Balance Sheet

INGR quarterly balance sheet

Metric	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Total Assets	$7.9B+6.1%	$7.4B-2.6%	$7.6B+1.1%	$7.6B+8.0%	$7.0B+2.1%	$6.9B+13.5%	$6.0B+5.4%	$5.7B-5.8%	$6.1B+5.2%	$5.8B+14.0%	$5.1B-0.2%	$5.1B-5.0%	$5.4B-4.3%	$5.6B+5.2%	$5.3B
Current Assets	$3.5B+4.5%	$3.4B-1.3%	$3.4B+2.7%	$3.3B+22.7%	$2.7B+1.9%	$2.6B+22.5%	$2.2B+1.0%	$2.1B-11.5%	$2.4B+7.2%	$2.3B+15.5%	$1.9B-9.0%	$2.1B-3.2%	$2.2B-6.2%	$2.4B+12.3%	$2.1B
Cash & Equivalents	$1.0B+3.3%	$997.0M+148.6%	$401.0M+69.9%	$236.0M-28.0%	$328.0M-50.7%	$665.0M+151.9%	$264.0M-19.3%	$327.0M-45.0%	$595.0M+16.2%	$512.0M+18.0%	$434.0M-25.2%	$580.0M+1.0%	$574.0M-5.7%	$609.0M+51.9%	$401.0M
Short-Term Investments	$3.0M-72.7%	$11.0M+37.5%	$8.0M+166.7%	$3.0M-25.0%	$4.0M	$0-100.0%	$4.0M-42.9%	$7.0M-22.2%	$9.0M+125.0%	$4.0M-33.3%	$6.0M-82.4%	$34.0M	$0-100.0%	$19.0M	$0
Inventory	$1.2B+3.4%	$1.2B-18.1%	$1.4B-9.2%	$1.6B+36.3%	$1.2B+27.8%	$917.0M+6.5%	$861.0M+4.5%	$824.0M+0.1%	$823.0M+4.3%	$789.0M+10.3%	$715.0M+2.3%	$699.0M-3.3%	$723.0M-13.3%	$834.0M+8.5%	$769.0M
Accounts Receivable	$1.2B+8.4%	$1.1B-14.5%	$1.3B-9.4%	$1.4B+24.9%	$1.1B+11.8%	$1.0B	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Long-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0-100.0%	$5.0M-54.5%	$11.0M+10.0%	$10.0M0.0%	$10.0M
Goodwill	$922.0M+1.8%	$906.0M-1.3%	$918.0M+2.0%	$900.0M-1.5%	$914.0M+1.3%	$902.0M+12.6%	$801.0M+1.3%	$791.0M-1.5%	$803.0M+2.4%	$784.0M+30.4%	$601.0M+25.7%	$478.0M-10.7%	$535.0M-3.9%	$557.0M-0.9%	$562.0M
Total Liabilities	$3.5B-0.6%	$3.6B-11.0%	$4.0B-7.1%	$4.3B+13.9%	$3.8B-0.3%	$3.8B+15.9%	$3.3B-2.2%	$3.3B+4.7%	$3.2B-0.9%	$3.2B+9.8%	$2.9B+0.8%	$2.9B-1.4%	$2.9B-6.5%	$3.2B-1.8%	$3.2B
Current Liabilities	$1.3B+2.7%	$1.3B-27.7%	$1.8B-5.8%	$1.9B+24.5%	$1.5B+3.7%	$1.5B+50.8%	$967.0M+2.2%	$946.0M-1.1%	$957.0M-2.1%	$978.0M+31.8%	$742.0M+2.9%	$721.0M-12.1%	$820.0M-12.1%	$933.0M+0.8%	$926.0M
Non-Current Liabilities	$2.2B-2.6%	$2.3B+2.4%	$2.2B-8.2%	$2.4B+6.9%	$2.3B-2.8%	$2.3B+1.2%	$2.3B-3.9%	$2.4B+7.3%	$2.2B-0.3%	$2.2B+2.3%	$2.2B+1293.6%	$157.0M-3.7%	$163.0M-45.1%	$297.0M+22.2%	$243.0M
Long-Term Debt	$1.7B-2.5%	$1.8B+2.7%	$1.7B-10.3%	$1.9B+11.6%	$1.7B-0.6%	$1.7B-1.0%	$1.8B-8.5%	$1.9B+10.7%	$1.7B-5.7%	$1.9B+1.7%	$1.8B+1.2%	$1.8B+4.7%	$1.7B-0.4%	$1.7B-4.3%	$1.8B
Total Equity	$4.3B+12.4%	$3.8B+7.5%	$3.5B+12.4%	$3.1B+1.5%	$3.1B+5.0%	$3.0B+8.5%	$2.7B+13.9%	$2.4B-17.4%	$2.9B+12.7%	$2.6B+19.6%	$2.1B-1.5%	$2.2B-9.4%	$2.4B-1.4%	$2.4B+15.8%	$2.1B
Retained Earnings	$5.6B+10.2%	$5.1B+9.4%	$4.7B+10.5%	$4.2B+8.0%	$3.9B-1.5%	$4.0B+4.7%	$3.8B+6.9%	$3.5B+8.5%	$3.3B+12.4%	$2.9B+13.6%	$2.6B+12.2%	$2.3B+11.2%	$2.0B+15.6%	$1.8B+25.3%	$1.4B

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-K	Q3'2510-K	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-K
Total Assets	$8.1B+3.7%	$7.9B+6.2%	$7.9B+6.1%	$7.8B+4.1%	$7.8B+7.8%	$7.5B+2.0%	$7.4B-2.6%	$7.5B-0.3%
Current Assets	$3.5B+0.2%	$3.5B+4.8%	$3.5B+4.5%	$3.5B+4.9%	$3.5B+13.5%	$3.4B+7.7%	$3.4B-1.3%	$3.4B+1.9%
Cash & Equivalents	$948.0M+10.1%	$914.0M+9.2%	$1.0B+3.3%	$915.0M+4.3%	$861.0M+70.5%	$837.0M+91.1%	$997.0M+148.6%	$877.0M+161.8%
Short-Term Investments	$4.0M-42.9%	$4.0M-55.6%	$3.0M-72.7%	$6.0M-14.3%	$7.0M+40.0%	$9.0M+28.6%	$11.0M+37.5%	$7.0M+16.7%
Inventory	$1.1B-9.3%	$1.2B+0.9%	$1.2B+3.4%	$1.2B-0.7%	$1.2B-1.7%	$1.2B-12.8%	$1.2B-18.1%	$1.2B-17.8%
Accounts Receivable	$1.4B+2.0%	$1.4B+5.8%	$1.2B+8.4%	$1.3B+11.8%	$1.4B+5.7%	$1.3B0.0%	$1.1B-14.5%	$1.2B-15.0%
Long-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0
Goodwill	$917.0M	$920.0M	$922.0M+1.8%	$921.0M-0.4%	N/A	N/A	$906.0M-1.3%	$925.0M+1.9%
Total Liabilities	$3.5B-0.2%	$3.5B+1.8%	$3.5B-0.6%	$3.5B+0.4%	$3.5B+1.8%	$3.4B-2.1%	$3.6B-11.0%	$3.5B-14.4%
Current Liabilities	$1.3B-0.4%	$1.3B+8.0%	$1.3B+2.7%	$1.3B+1.8%	$1.3B+2.8%	$1.2B-7.9%	$1.3B-27.7%	$1.3B-24.8%
Non-Current Liabilities	$2.2B-0.1%	$2.2B-1.5%	$2.2B-2.6%	$2.2B-0.4%	$2.2B+1.3%	$2.2B+1.2%	$2.3B+2.4%	$2.2B-7.2%
Long-Term Debt	$1.7B+0.1%	$1.7B0.0%	$1.7B-2.5%	$1.7B0.0%	$1.7B0.0%	$1.7B+0.1%	$1.8B+2.7%	$1.7B-10.3%
Total Equity	$4.5B+7.8%	$4.4B+10.2%	$4.3B+12.4%	$4.2B+7.3%	$4.2B+13.3%	$4.0B+6.8%	$3.8B+7.5%	$4.0B+17.4%
Retained Earnings	$5.8B+7.1%	$5.7B+8.9%	$5.6B+10.2%	$5.5B+8.9%	$5.4B+9.5%	$5.2B+8.7%	$5.1B+9.4%	$5.0B+10.4%

INGR Cash Flow Statement

INGR quarterly cash flow statement

Metric	TTM	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Operating Cash Flow	$805.0M	$944.0M-34.3%	$1.4B+35.9%	$1.1B+595.4%	$152.0M-61.2%	$392.0M-52.7%	$829.0M+21.9%	$680.0M-3.3%	$703.0M-8.6%	$769.0M-0.3%	$771.0M+12.4%	$686.0M-6.2%	$731.0M+18.1%	$619.0M-15.4%	$732.0M+144.0%	$300.0M
Depreciation & Amortization	N/A	$222.0M+3.7%	$214.0M-2.3%	$219.0M+1.9%	$215.0M-2.3%	$220.0M+3.3%	$213.0M-3.2%	$220.0M-10.9%	$247.0M+18.2%	$209.0M+6.6%	$196.0M+1.0%	$194.0M-0.5%	$195.0M+0.5%	$194.0M-8.1%	$211.0M0.0%	$211.0M
Stock-Based Compensation	N/A	$40.0M+8.1%	$37.0M+12.1%	$33.0M+13.8%	$29.0M+26.1%	$23.0M0.0%	$23.0M+27.8%	$18.0M-14.3%	$21.0M-19.2%	$26.0M-7.1%	$28.0M+33.3%	$21.0M+10.5%	$19.0M+11.8%	$17.0M-5.6%	$18.0M+63.6%	$11.0M
Capital Expenditures	$450.0M	$433.0M+46.8%	$295.0M-6.1%	$314.0M+4.7%	$300.0M0.0%	$300.0M-11.8%	$340.0M+3.7%	$328.0M-6.3%	$350.0M+11.5%	$314.0M+10.6%	$284.0M+1.4%	$280.0M+1.4%	$276.0M-7.4%	$298.0M-4.8%	$313.0M+19.0%	$263.0M
Free Cash Flow	$355.0M	$511.0M-55.2%	$1.1B+53.6%	$743.0M+602.0%	-$148.0M-260.9%	$92.0M-81.2%	$489.0M+38.9%	$352.0M-0.3%	$353.0M-22.4%	$455.0M-6.6%	$487.0M+20.0%	$406.0M-10.8%	$455.0M+41.7%	$321.0M-23.4%	$419.0M+1032.4%	$37.0M
Investing Cash Flow	-$343.0M	-$444.0M-844.7%	-$47.0M+85.7%	-$329.0M-2.8%	-$320.0M+4.5%	-$335.0M+41.3%	-$571.0M-52.7%	-$374.0M-3.6%	-$361.0M-10.7%	-$326.0M+52.7%	-$689.0M-6.2%	-$649.0M	N/A	N/A	N/A	N/A
Financing Cash Flow	-$376.0M	-$491.0M+35.8%	-$765.0M-34.4%	-$569.0M-652.4%	$103.0M+127.6%	-$373.0M-360.8%	$143.0M+139.3%	-$364.0M+38.2%	-$589.0M-57.1%	-$375.0M	N/A	-$116.0M	N/A	N/A	N/A	N/A
Dividends Paid	$210.0M	$211.0M+0.5%	$210.0M+8.2%	$194.0M+7.2%	$181.0M-1.6%	$184.0M+3.4%	$178.0M+2.3%	$174.0M-4.4%	$182.0M+10.3%	$165.0M+17.0%	$141.0M+11.9%	$126.0M-1.6%	$128.0M+14.3%	$112.0M+62.3%	$69.0M+38.0%	$50.0M
Share Buybacks	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	$123.0M+1437.5%	$8.0M-80.5%	$41.0M-86.5%	$304.0M+33.3%	$228.0M+1166.7%	$18.0M-62.5%	$48.0M

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-K	Q3'2510-K	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-K
Operating Cash Flow	$90.0M-51.4%	$33.0M-57.1%	$405.0M-7.1%	$277.0M-42.2%	$185.0M-40.7%	$77.0M-63.2%	$436.0M+6.3%	$479.0M+30.2%
Depreciation & Amortization	$55.0M+3.8%	$55.0M0.0%	$57.0M+5.6%	$57.0M+7.5%	$53.0M-1.9%	$55.0M+3.8%	$54.0M0.0%	$53.0M-5.4%
Stock-Based Compensation	$8.0M-27.3%	$10.0M-23.1%	N/A	$9.0M+12.5%	$11.0M+22.2%	$13.0M0.0%	N/A	$8.0M-11.1%
Capital Expenditures	$100.0M-1.0%	$110.0M+19.6%	$135.0M+8.0%	$105.0M+110.0%	$101.0M+83.6%	$92.0M+41.5%	$125.0M+54.3%	$50.0M-36.7%
Free Cash Flow	-$10.0M-111.9%	-$77.0M-413.3%	$270.0M-13.2%	$172.0M-59.9%	$84.0M-67.3%	-$15.0M-110.4%	$311.0M-5.5%	$429.0M+48.4%
Investing Cash Flow	-$2.0M+98.4%	-$100.0M-28.2%	-$142.0M-12.7%	-$99.0M-115.2%	-$125.0M-123.2%	-$78.0M-143.1%	-$126.0M-44.8%	-$46.0M+43.9%
Financing Cash Flow	-$53.0M-6.0%	-$48.0M+71.1%	-$151.0M+7.9%	-$124.0M-65.3%	-$50.0M+72.1%	-$166.0M+52.2%	-$164.0M+38.8%	-$75.0M+63.2%
Dividends Paid	$53.0M-1.9%	$52.0M0.0%	$54.0M0.0%	$51.0M-1.9%	$54.0M+1.9%	$52.0M+2.0%	$54.0M+5.9%	$52.0M+8.3%

Not reported in any period shown, so not listed: Share Buybacks.

INGR Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

INGR quarterly financial ratios

Metric	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Gross Margin	25.3%+1.2pp	24.1%+2.7pp	21.4%+2.6pp	18.8%-0.5pp	19.3%-1.9pp	21.3%+0.1pp	21.1%-0.6pp	21.8%-1.8pp	23.6%-1.0pp	24.6%+2.5pp	22.1%+2.4pp	19.7%+1.8pp	17.9%-1.1pp	18.9%+0.8pp	18.1%
Operating Margin	14.1%+2.2pp	11.9%+0.2pp	11.7%+2.1pp	9.6%+5.1pp	4.5%-5.2pp	9.7%-1.0pp	10.7%-0.5pp	11.2%-2.2pp	13.4%-0.7pp	14.1%+2.4pp	11.7%+1.5pp	10.3%+0.6pp	9.7%-0.5pp	10.2%-0.6pp	10.8%
Net Margin	10.1%+1.4pp	8.7%+0.8pp	7.9%+1.7pp	6.2%+4.5pp	1.7%-4.1pp	5.8%-0.8pp	6.7%-0.4pp	7.0%-1.3pp	8.3%-0.2pp	8.5%+1.4pp	7.1%+0.9pp	6.3%0.0pp	6.3%-0.3pp	6.6%-0.3pp	6.8%
Return on Equity	17.1%+0.1pp	17.0%-1.2pp	18.2%+2.5pp	15.6%+11.9pp	3.8%-8.0pp	11.8%-3.4pp	15.2%-3.4pp	18.6%+0.6pp	17.9%-1.0pp	18.9%+0.2pp	18.8%+2.4pp	16.3%-0.2pp	16.5%-1.1pp	17.6%-2.5pp	20.1%
Return on Assets	9.2%+0.5pp	8.7%+0.3pp	8.4%+1.9pp	6.5%+4.8pp	1.7%-3.4pp	5.1%-1.8pp	6.8%-0.9pp	7.7%-0.8pp	8.5%+0.2pp	8.4%+0.5pp	7.9%+0.9pp	7.0%-0.4pp	7.4%-0.3pp	7.6%-0.3pp	8.0%
Current Ratio	2.660.0x	2.62+0.7x	1.92+0.2x	1.760.0x	1.780.0x	1.82-0.4x	2.230.0x	2.26-0.3x	2.52+0.2x	2.30-0.3x	2.63-0.3x	2.97+0.3x	2.70+0.2x	2.53+0.3x	2.27
Debt-to-Equity	0.41-0.1x	0.470.0x	0.49-0.1x	0.62+0.1x	0.560.0x	0.59-0.1x	0.65-0.2x	0.81+0.2x	0.60-0.1x	0.72-0.1x	0.850.0x	0.83+0.1x	0.710.0x	0.71-0.1x	0.86
Asset Turnover	0.91-0.1x	1.00-0.1x	1.070.0x	1.05+0.1x	0.98+0.1x	0.87-0.2x	1.03-0.1x	1.10+0.1x	1.030.0x	0.99-0.1x	1.110.0x	1.11-0.1x	1.180.0x	1.170.0x	1.17
FCF Margin	7.1%-8.3pp	15.4%+6.2pp	9.1%+11.0pp	-1.9%-3.2pp	1.3%-6.8pp	8.2%+2.5pp	5.7%+0.1pp	5.6%-1.7pp	7.3%-1.2pp	8.5%+1.3pp	7.2%-0.8pp	8.0%+3.0pp	5.1%-1.3pp	6.4%+5.8pp	0.6%

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-K	Q3'2510-K	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-K
Gross Margin	23.0%-3.0pp	22.4%-3.3pp	24.5%-0.5pp	25.1%-0.6pp	26.0%+2.3pp	25.7%+3.5pp	24.9%+4.1pp	25.6%+4.9pp
Operating Margin	10.2%-4.6pp	11.3%-3.9pp	N/A	13.7%-0.6pp	14.8%+2.0pp	15.2%+3.9pp	N/A	14.3%+3.9pp
Net Margin	6.2%-4.5pp	7.9%-2.9pp	9.4%+4.1pp	9.4%-0.6pp	10.7%+2.8pp	10.9%-0.6pp	5.3%-1.5pp	10.1%+2.3pp
Return on Equity	2.5%-2.1pp	3.2%-1.7pp	3.9%+1.4pp	4.0%-0.7pp	4.7%+0.7pp	5.0%-0.9pp	2.5%-1.2pp	4.8%+0.1pp
Return on Assets	1.4%-1.1pp	1.8%-0.9pp	2.1%+0.8pp	2.2%-0.3pp	2.5%+0.5pp	2.6%-0.3pp	1.3%-0.4pp	2.5%+0.4pp
Current Ratio	2.800.0x	2.76-0.1x	2.660.0x	2.75+0.1x	2.78+0.3x	2.85+0.4x	2.62+0.7x	2.67+0.7x
Debt-to-Equity	0.390.0x	0.400.0x	0.41-0.1x	0.410.0x	0.41-0.1x	0.440.0x	0.470.0x	0.44-0.1x
Asset Turnover	0.230.0x	0.230.0x	0.220.0x	0.230.0x	0.240.0x	0.240.0x	0.240.0x	0.250.0x
FCF Margin	-0.5%-5.1pp	-4.3%-3.5pp	15.4%-1.9pp	9.5%-13.5pp	4.6%-9.1pp	-0.8%-8.5pp	17.3%+0.2pp	22.9%+8.7pp

Similar Companies

Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.

Company	Fiscal year	Revenue	Net income	Net margin	Market cap	Health score
Ingredion Incorporated INGR	FY2025	$7.2B	$729.0M	10.1%	$6.0B	60/100
Lamb Weston Holdings, Inc. LW	FY2026	$6.6B	$290.0M	4.4%	$6.6B	46/100
Smithfield Foods, Inc. SFD	FY2025	$15.5B	$987.0M	6.4%	$7.3B	57/100
Conagra Brands, Inc. CAG	FY2026	$11.3B	-$1.9B	-17.0%	$6.4B	33/100
POST HOLDINGS, INC. POST	FY2025	$8.2B	$335.7M	4.1%	$3.4B	51/100

Where Ingredion Incorporated Ranks

Frequently Asked Questions

What is Ingredion Incorporated's annual revenue?

Ingredion Incorporated (INGR) reported $7.2B in total revenue for fiscal year 2025. This represents a -2.8% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Ingredion Incorporated's revenue growing?

Ingredion Incorporated (INGR) revenue declined by 2.8% year-over-year, from $7.4B to $7.2B in fiscal year 2025.

Is Ingredion Incorporated profitable?

Yes, Ingredion Incorporated (INGR) reported a net income of $729.0M in fiscal year 2025, with a net profit margin of 10.1%.

What is Ingredion Incorporated's EBITDA?

Ingredion Incorporated (INGR) had EBITDA of $1.2B in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

How much debt does Ingredion Incorporated have?

As of fiscal year 2025, Ingredion Incorporated (INGR) had $1.0B in cash and equivalents against $1.7B in long-term debt.

What is Ingredion Incorporated's gross margin?

Ingredion Incorporated (INGR) had a gross margin of 25.3% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

What is Ingredion Incorporated's operating margin?

Ingredion Incorporated (INGR) had an operating margin of 14.1% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

What is Ingredion Incorporated's net profit margin?

Ingredion Incorporated (INGR) had a net profit margin of 10.1% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

What is Ingredion Incorporated's return on equity (ROE)?

Ingredion Incorporated (INGR) has a return on equity of 17.1% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

What is Ingredion Incorporated's free cash flow?

Ingredion Incorporated (INGR) generated $511.0M in free cash flow during fiscal year 2025. This represents a -55.2% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is Ingredion Incorporated's operating cash flow?

Ingredion Incorporated (INGR) generated $944.0M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

What are Ingredion Incorporated's total assets?

Ingredion Incorporated (INGR) had $7.9B in total assets as of fiscal year 2025, including both current and long-term assets.

What are Ingredion Incorporated's capital expenditures?

Ingredion Incorporated (INGR) invested $433.0M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

How much does Ingredion Incorporated spend on research and development?

Ingredion Incorporated (INGR) invested $71.0M in research and development during fiscal year 2025.

How many shares does Ingredion Incorporated have outstanding?

Ingredion Incorporated (INGR) had 63M shares outstanding as of fiscal year 2025.

What is Ingredion Incorporated's current ratio?

Ingredion Incorporated (INGR) had a current ratio of 2.66 as of fiscal year 2025, which is generally considered healthy.

What is Ingredion Incorporated's debt-to-equity ratio?

Ingredion Incorporated (INGR) had a debt-to-equity ratio of 0.41 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is Ingredion Incorporated's return on assets (ROA)?

Ingredion Incorporated (INGR) had a return on assets of 9.2% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is Ingredion Incorporated's P/E ratio?

Ingredion Incorporated (INGR) trades at 10.1x earnings, its market capitalization divided by net income of $592.0M net income, trailing 12 months to June 30, 2026. The market capitalization is $6.0B as of Oct 10, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

What is Ingredion Incorporated's price-to-sales ratio?

Ingredion Incorporated (INGR) trades at 0.8x sales, its market capitalization divided by revenue of $7.2B revenue, trailing 12 months to June 30, 2026. The market capitalization is $6.0B as of Oct 10, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

What is Ingredion Incorporated's Altman Z-Score?

Ingredion Incorporated (INGR) has an Altman Z-Score of 3.68, placing it in the Safe Zone (low bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

What is Ingredion Incorporated's Piotroski F-Score?

Ingredion Incorporated (INGR) has a Piotroski F-Score of 8 out of 9, indicating strong financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are Ingredion Incorporated's earnings high quality?

Ingredion Incorporated (INGR) has an earnings quality ratio of 1.29x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

How financially healthy is Ingredion Incorporated?

Ingredion Incorporated (INGR) scores 60 out of 100 on our Financial Health Score, indicating moderate standing within its operating companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.